Author:
Scartozzi M,Galizia E,Verdecchia L,Berardi R,Graziano F,Catalano V,Giordani P,Mari D,Silva R R,Marmorale C,Zingaretti C,Cascinu S
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas. Cancer 94: 2862–2866
2. Burkhard HA von Rahden, Stein HJ, Feith M, Becker K, Siewert JR (2005) Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol 23: 874–879
3. Cascinu S, Labianca R, Barone C, Carnaghi C, Aitini E, Frontini L, Catalano V, Bertetto O, Barni S, Floriani I (2005) An intensive weekly chemotherapeutic regimen with 5fluorouracil, leucovorin, cisplatin and epidoxorubicin (PELFw) as adjuvant treatment in high-risk radically resected gastric cancer patients: results of a randomised controlled trial. ECCO 2005, abstract 720
4. Cunningham D, Allum WH, Stenning SP, Weeden S, for the NCRI Upper GI Cancer Clinical Studies Group (2005) Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). Proceedings of the ASCO 2005, abstract 4001
5. Duraker N, Sisman S, Can G (2003) The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today 33: 95–100
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献